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Background
Maintaining DNA integrity is essential for cell survival and
proper functioning. Therefore, many cancer therapies,
including radiotherapy and several chemotherapeutic
drugs, induce damage to the DNA leading to genomic
instability [1]. There are several DNA damage responses
(DDRs) which can be activated depending on the type and
the extent of DNA damage [1]. These responses involve
detection of the damage by several proteins including,
poly (ADP-ribose) polymerase (PARP), which can directly
or indirectly affect metabolism [1].
Materials and methods
We have used NMR based targeted profiling [2] to com-
pare different DNA damage responses and study the effect
of PARP inhibition on metabolism in the MCF-7 cell line.
Methyl methanesulphonate (MMS), cisplatin, g-radiation,
and zeocin; were used to trigger different DDRs. ABT-888
(Veliparib) was used to study the effect of PARP inhibition
on metabolism, both as a single agent and in combination
with DNA damaging agents.
Results
We observed several similarities in the metabolic
responses caused by different DDRs and also identified
specific metabolite markers on treatment with these DNA
damaging agents. PARP inhibition restored most of the
metabolic changes observed in MMS-treated cells suggest-
ing that the metabolic response observed after MMS treat-
ment may be predominantly due to PARP activation.
Conclusions
In this study, we identified several similarities and differ-
ences in metabolic responses induced by different types of
DDRs, which suggests the redirection of metabolic fluxes
in a DNA damage-dependent manner. We also observed
that recruitment of PARP during the DNA repair process
can lead to widespread metabolic changes by observing
the effect of PARP inhibition in MMS-treated cells. These
results have identified novel metabolic responses in cancer
cells following DNA damage and on inhibiting activity of
proteins involved in DNA repair processes.
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